Group Advance Care Planning for Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if group educational sessions about advance care planning (deciding on future medical care) are more effective than just receiving written materials. The goal is to assist people with newly diagnosed cancer in making informed decisions about their care. Participants will either continue with their usual care and receive some written information or attend group sessions to learn more about planning their future medical care. This trial suits English-speaking adults who have been recently diagnosed with cancer and can provide verbal consent. As an unphased trial, this study offers participants the opportunity to contribute to valuable research that could enhance future care planning for cancer patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this group advance care planning education is safe?
Research shows that group advance care planning (ACP) education involves no drugs or medical procedures. It helps individuals plan their future medical care based on their personal values. While specific safety data for this type of education is lacking, similar studies in palliative care, which emphasize comfort, typically present very low risk. Participants often feel more prepared and supported when making important decisions about their care. This suggests that group ACP education is a safe and effective method for planning healthcare needs.12345
Why are researchers excited about this trial?
Researchers are excited about the Group Advance Care Planning Education because it offers a fresh approach to cancer care by focusing on proactive communication and planning. Unlike traditional treatments that primarily concentrate on medical interventions, this method emphasizes empowering patients through education about their care options and goals. By engaging patients in group educational sessions, it encourages more open discussions and better understanding of individual care preferences, which may lead to improved patient satisfaction and quality of life. This approach could redefine how we support cancer patients, making the care process more personalized and aligned with their values.
What evidence suggests that Group Advance Care Planning Education is effective for cancer patients?
Research has shown that group sessions on advance care planning, which participants in this trial may receive, greatly help patients ensure their medical care aligns with their personal goals. Studies have found that this approach significantly increases the likelihood of completing advance directives, with participants more likely to prepare these important documents. Additionally, patients in these programs often communicate better and make more informed decisions about their future healthcare. Reviews indicate that advance care planning can lead to care that aligns more closely with patients' wishes. Overall, these findings suggest that group sessions serve as a valuable tool for patients in planning their care effectively.12367
Are You a Good Fit for This Trial?
This trial is for veterans with an advanced stage cancer diagnosis. It's designed to help them learn about advanced care planning through group educational sessions, which may also provide a supportive environment.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants engage in group advanced care planning sessions or receive usual care
Follow-up
Participants are monitored for documentation of goals of care and other secondary outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Group Advance Care Planning Education
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor
VA Palo Alto Health Care System
Lead Sponsor
US Department of Veterans Affairs
Collaborator
ci2i
Collaborator